Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.8670
-0.0330 (-3.67%)
At close: May 9, 2025, 4:00 PM
0.8670
0.00 (0.00%)
After-hours: May 9, 2025, 4:00 PM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $34.97 million as of May 9, 2025. Its market cap has decreased by -64.20% in one year.
Market Cap
34.97M
Enterprise Value
-52.22M
1-Year Change
-64.20%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $34.97M, a decrease of -93.96%. That is a compound annual growth rate of -50.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 34.97M | -28.03% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |